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z.2012.12Abstract There are at least 16 types of collagen. Antibodies, to collagens, in particular to types I
and II have been reported in a number of autoimmune diseases. In this study, we used rat and
bovine collagens to study the effects of anti-collagen antibodies on the lymphoid organs of rats His-
tological examination of the lymph node sections showed that immunization with different collagen
types combined with the adjuvant used in this study induced arthritis and immune reaction in
lymph nodes. The degrees of the disease symptoms and immune reaction depended on the foreign-
ness of the stimulating collagen and on whether it was accompanied with adjuvant. Anti-collagen
antibodies led to a decrease in the thickness of the lymph node cortex and atrophy, with medullary
hyperplasia, small granulomas appeared in the section. Immunizing with either bovine collagen or
BSA has shown a remarkable distortion in architecture appeared, follicular hyperplasia and reactive
inﬂammatory hyperplasia of the LN. Passive transfer of rat anti-rat collagen antibodies either
accompanied with Freund’s adjuvant or not with a lesser degree of severity, resulted in epithelioid
cells forming granuloma surrounded by collar of lymphocytes, scattered apoptotic bodies, lympha-
tic sinus ectasia accompanied with lymphoid follicles atrophy. The results of our study present a
reliable model for collagen induced arthritis which is suitable for the investigation of the mechanism
of disease induction and treatment approaches.
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.005Introduction
It is generally assumed that themain job of the immune system is
to distinguish betweenwhat is self and non self. Once the distinc-
tion has beenmade, self is preserved and non self is destroyed.At
the most general level, this is true, and human beings remain
alive and healthy only because it is so. It has become clear; how-
ever, that at the ﬁner level of detail the distinction between self
and other is not absolute (Rose and Mackay, 2006).and hosting by Elsevier B.V. All rights reserved.
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sues, and organs that work together to protect the body
against infectious organisms and other invaders. Through a
series of events called the immune response, the immune sys-
tem attacks organisms and substances that invade body sys-
tems and cause disease. The cells of the immune system are
organized into speciﬁc structures called central lymphoid tis-
sues which include bone marrow, thymus, and peripheral lym-
phoid tissues which include lymph nodes, spleen, and mucosa-
associated lymphoid tissues (Schindler, 1991).
In both cell-mediated and humoral responses, the recogni-
tion of antigen by receptors present on the lymphocyte surface
promotes changes in the morphology of the lymphocyte
(Daugherty and Hansson, 2000). A humoral immune response
takes place when the antigenic determinant is recognized by B-
lymphocytes which differentiate to plasma cells upon their
activation. B cells have the capacity to synthesize and secrete
antibodies (immunoglobulin) that are speciﬁc for and complex
with the antigenic determinant (Kathryn et al., 2007). Upon
recognition of the antigen and induction of humoral immune
response, germinal centers (GCs) are formed within LNs. His-
tologically; GCs describe microscopically distinguishable parts
in lymphoid tissues. GCs appear pale in staining because most
of their cells are large and their cytoplasm is abundant and
pale in staining. It contains large lymphocytes, a large number
of medium sized lymphocytes, lymphoblasts, plasma cells and
macrophages. All these cells are anchored in a network from
the dendrites of the follicular dendritic cells interacting with
antigen-reactive B cells (Meyer-Hermann, 2002).
The GC reaction is a complex process that requires at least
three cellular components: follicular dendritic cells (FDCs),
antigen speciﬁc helper T lymphocytes, and B lymphocytes
(Kelsoe, 1995, 2008). The GC forms a specialized micro-envi-
ronment that participates in the proliferation and differentia-
tion of B lymphocytes (Klaus et al., 1980; MacLennan and
Gray, 1986; Tew et al., 1989). The major constituents of
GCs are activated B lymphocytes and follicular dendritic cells
(FDCs) with some macrophages and T-lymphocytes (Butcher
et al., 1982).
Collagens are the most abundant proteins found in the ani-
mal kingdom. It is the major protein comprising the extracel-
lular matrix (ECM). There are at least 30 different collagen
genes dispersed through the human genome. These 30 genes
express proteins that combine in a variety of ways to create
over 20 different types of collagen ﬁbrils. Types I, II and III
are the most abundant and form ﬁbrils of similar structure.
Type IV collagen forms a two-dimensional reticulum and is
a major component of the basal lamina. Collagens are mainly
synthesized by ﬁbroblasts with some contribution from epithe-
lial cells (Layman et al., 1971; Paz Mercedes and Gallop, 2010;
Killen and Striker, 1979).
Collagen is a primary component of the connective tissue
located in the dermis, the tough inner layer of the skin. This
kind of connective tissue is also found in mucous membranes,
nerves, blood vessels, and organs. Collagen in these structures
imparts strength, support, and a certain amount of elasticity.
Collagen is also a component of a kind of connective tissue
that surrounds organs. This connective tissue encases and pro-
tects delicate organs like the kidneys and spleen. Collagens
also, are widely employed in the construction of artiﬁcial skin
substitutes used in the management of severe burns (Liu et al.,
2002). However, this treatment is controversial since manypeople develop allergic reactions to collagen (Askari et al.,
2011; Tang et al., 2011).
Antibodies to native and denatured collagens, in particular
to types I and II, have been reported in a number of diseases
including ankylosing spondylitis, emphysema, gout, juvenile
chronic arthritis, lepromatous leprosy, osteoarthritis, paget’s
disease, psoriatic arthritis, relapsing polychondritis, rheuma-
toid arthritis (RA), scleroderma, systemic lupus erythmatosus,
and traumatic synovitis (Clague et al., 1981; Ebringer et al.,
1981; Trentham, 1981; Stuart et al., 1983; Morgan et al.,
1987; Choi et al., 1988; Charriere et al., 1988).
Collagen-induced arthritis (CIA) is an experimental auto-
immune disease and the most widely used mouse model for hu-
man rheumatoid arthritis (RA) (Luross and Williams, 2001;
Myers et al., 1997). CIA can be elicited in susceptible strains
of rodents (rat and mouse) and non-human primates by immu-
nization with type II collagen, the major constituent protein of
articular cartilage. Following immunization, these animals de-
velop an autoimmune polyarthritis that shares several clinical
and histological features with RA. Susceptibility to CIA in ro-
dents is linked to the class II molecules of the major histocom-
patibility complex (MHC). The immune response to collagen
II are characterized by both the stimulation of collagen-speciﬁc
T cells and the production of high titers of antibody speciﬁc for
both the immunogenic collagen whether it is autologous or
heterologous (Williams, 2007).
CIA is an experimental auto-immune model that provides
the opportunity to investigate the role of a deﬁned auto-antigen
in the disease induction and progression. Both T-cell and B-cell
mediated immune responses have been implicated as having
important roles in the pathogenesis of CIA (Stuart and Dixon,
1983; Holmdahl et al., 1985b). The induction of collagen arthri-
tis as well as the induction of an antibody response toward type
II collagen is intimately associated with the expression of certain
class IIMHCgenes (Wooley et al., 1981;Holmdahl andHansen,
1986a). These suggest that auto-antibodies related to type II col-
lagen may play an important role in immunoregulation and, in
this context, may be an example of dysregulation in the control
of pathogenic autoimmunity.With this regard, it was possible to
induce arthritis after immunization with autologous type II col-
lagen (Trentham et al., 1977; Holmdahl et al., 1985a). Further-
more, both B cells and T cells from arthritis-susceptible strains
can be activated with autologous type II collagen (Holmdahl
et al., 1985a, b). In this work, we aimed to study the effect of
anti-collagen immune response toward autologous and heterol-
ogous collagens on some lymphoid tissues in rats.Materials and methods
Animals
Inbred Male and female albino rats of Charles River strain
(Rattus rattus) obtained from the ‘‘animal house’’ of Asyut
University, Egypt, were used just after suckling period
(8 weeks old). Animals were kept in rat cages in the animal
house at room temperature for about two weeks to reach their
optimal conditions of weight and maturity. The humidity was
adjusted and the animal house was made sure to be infection
free. Food and drinking water were provided ad libitum. Ani-
mal care and use were inspected and approved by the depart-
ment committee.
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Rats were sacriﬁced, and their tails were washed in distilled
water and the skin was removed completely, and then the lon-
gitudinal tendons were extracted from rat tails. The extraction
of rat tail collagen (Q collagen) and solution fabrication was
run according to Habermehi (2005). For extraction of bovine
collagen, the same method as for rat tail collagen extraction
was applied but with using tendon of Achilles of bovine in-
stead of the rat tail. A card with pertinent experimental infor-
mation was fastened to the outside of the cage where the
animals were housed.
Adjuvant preparation
Crude lipopolysaccharides (LPS) of Pseudomonos preparation
was run according to Apicella (2008) and Al-Hendy et al.
(1991). Exactly 8.5 ml of mineral oil, 1.5 ml Arlacel A, and
50 mg LPS were mixed thoroughly, the mixture was auto-
claved for 15 min at 15 Lbs.
Antigen-adjuvant emulsion preparation
Sterile solutions of antigenwere prepared by ﬁltration through a
Millipore ﬁlter. 10 ml of 10% potassium alum was added to
25 ml of 1% solution of antigen drop wise with stirring. The
pH of the mixture was adjusted to be 6.5 by drop wise addition,
with stirring, using 1 N NaOH and was let to stand for 30 min.
The suspension was centrifuged at about 1000g, at about 5 C
for 10 min. The supernatant ﬂuidwas decanted and saved.More
than 99%of the antigen was adsorbed to alum by estimating the
amount of protein remaining in the supernatant ﬂuid according
to the method of Henry (1964). The precipitate was washed
twice by gentle inversion in about 50 ml of saline and recovered
each time by centrifugation. The washed precipitate was re-sus-
pended in 25 ml of saline and stored at 4 C. Of alum-precipi-
tated antigen 10 ml was drawn into 10 ml syringe and added in
aliquots of 1–1.5 ml to themixture prepared in the 1st step (opti-
mal emulsiﬁcation is obtained using equal volumes of antigen
solution and adjuvant (Fischel et al., 1952; Munoz 1964; Wil-
liams and Chase 1967). The mixture was emulsiﬁed thoroughly
after each addition of the antigen by ejection of the emulsion
drawn repeatedly into a 20 ml syringe with a 13 gauge needle.
The emulsion was made just prior to use.
Preparation of anti-sera and sera collection
This study was designed to include two treatment conditions.
The ﬁrst treatment condition is based on immunization of rats
with the antigen (collagen, or BSA) combined with adjuvant.
The collagen induced arthritis is referred as CIA. The second
treatment condition was based on passive transfer of rat sera
including anti-collagen antibodies which is referred as anti-
body induced arthritis (AIA). The ﬁrst treatment condition in-
cluded about 18 mature albino rats their weight ranged from
80 to 120 g, were divided into three groups of six rats each.
Group (A1), was immunized with one ml of the emulsion of
the rat collagen combined with adjuvant. Group (A2), received
an immunization with one ml of the emulsion of bovine colla-
gen combined with adjuvant. Group (A3), was injected with
one ml of the emulsion of bovine serum albumin (BSA)combined with adjuvant, this group served as negative control
group to collagen. The three groups were injected twice, two
weeks apart. Sera were collected from each group after 5 days
of the 2nd immunization and then stored at 20 C.
During the ﬁrst condition of the experiment; Animals were
immunized twice; the ﬁrst immunization was induced with one
ml of emulsion as 0.1 ml of emulsion for each footpad, 0.1 ml
for each side of the neck and 0.4 ml for intraperitoneal injection.
The second shot was run with 0.7 ml of emulsion as 0.1 ml for
each footpad, 0.1 ml for each side of the neck and 0.1 ml for
intraperitoneal injection. In the second condition of the experi-
ment; the dose (sera of ﬁrst condition animals) was divided into
ﬁrst shot and second shot two weeks apart. The same doses as
the ﬁrst condition were applied. Four days later, the animals
were immunized with one ml of adjuvant only.
In the second treatment conditions rats were divided into
ﬁve groups, of 6 rats each. Group (B1) rats were injected with
one ml of serum containing anti-rat‘s collagen Abs (obtained
from the serum of group A1 in the ﬁrst treatment condition).
After two weeks, rats received 0.7 ml of serum as a boost dose
without immunization with adjuvant. After four days of the
2nd antibody treatment, the rats were immunized with adju-
vant only.
Group (B2) was treated as group B1 but without immuniza-
tionwith adjuvant.Group (B3) was injected twice, 1 week apart,
with oneml of serum containing anti-bovine‘s collagenAbs (ser-
um of group A2). Rats received 0.7 ml of serum as a boost dose
then immunized with one ml of adjuvant four days later. Group
(B4) Rats was injected as in group 3 but without immunization
with adjuvant. Group (B5) was injected twice, 1 week apart;
with serum of anti-bovine serum albumin (BSA) antibodies (ob-
tained from group A3 in the 1st treatment condition) followed
four days later by immunization with the adjuvant only.
At the end of the experiment the animals were fastened for
12 h prior to bleeding to reduce plasma lipid. Blood was col-
lected from the jugular vein in the neck where a thick needle
was inserted into the neck at the position of the vein; the blood
was allowed to drip into clean tubes. The tubewas kept on ice for
ﬁve minutes to allow slow blood coagulation. The serum was
collected, pooled together for each group and kept at 20 C
until use.
Histological preparations
The animals were narcotized, after the determined period of
treatment, the animal under anesthesia was dissected, the cer-
vical, auxiliary, brachial, inguinal, femoral and mesenteric
lymph nodes, and spleen, were collected and prepared for his-
tological examination. All the chosen lymph nodes are located
in the lymph drainage route. The organs were washed in saline
solution and run through the routine histological H&E tech-
nique of Drury and Wallington (1980).
Results
Animal’s general health conditions and internal organs during
dissection
Control group rats looked ﬁne with normal vital activities after
injection where there were no signs of illness or swelling and
redness in the sites of injection. At the time of animal
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size and shape. The rats of other groups after injection either
with emulsion containing antigen in the 1st condition or the
passive transfer of anti collagen antibodies in the 2nd condi-
tion, were not looking well. They appeared weak and ex-
hausted especially the groups that were immunized with
either collagen or BSA (groups of the ﬁrst condition). Once
they were injected, swelling and redness of the injected joints
started (Fig. 1a and b), and the movement of rats decreased,
gradually swelling and redness increased and movement de-
creased until about ﬁve days. After ﬁve days the swelling was
ameliorated and the movement was improved. The redness re-
mained for about 15 days after injection. The inﬂammation of
joint disappeared completely after about 38 or 40 days after
injection. The groups that received a passive transfer withFigure 1 (a) A photograph showing the inﬂammation of fore limb.
photograph showing the granulomas at the injection site (neck).
Figure 2 Photomicrographs of lymph node section of control gro
architecture with primary and secondary lymphoid follicles (arrows) be
(b) higher magniﬁcation of a secondary lymphoid follicle containing gthe serum containing antibodies (AIA) appeared better than
the groups immunized with either collagen (CIA) or BSA.
After about half an hour from injection, the joints swelled
and became blue in color; the rats scarcely could move and ap-
peared tired. After one week from the ﬁrst injection, the
inﬂammation of joints improved and completely disappeared
after 10 days. In all groups, at the sites of injection (neck),
there were granulomas (Fig. 1c); with a half ball shape point-
ing internally from the dermis. The lymph nodes generally
were enlarged compared to control groups, but those of the
groups immunized with collagen were less tangible than of
the groups treated with passive transfer of serum containing
antibodies (the second condition groups).
Histological examination of the lymph node section of the
control group is shown in (Fig. 2), the cortex contained a num-(b) A photograph showing the inﬂammation of hind limb. (c) A
up: (a) low microscopic power showing the normal lymph node
low the capsule in the cortex, the medulla appear in the center (4·),
erminal center (GC) (pale staining area) (40·) (H & E).
Figure 3 Photomicrograph of lymph node section of group A1 (1st condition of the experiment): (a) showing the decrease in the
thickness of the cortex (lymph node depletion or atrophy) with hyperplasia (4·). (b) Showing lymphoid follicle (LF) containing germinal
center (GC) (10·). (c) Higher magniﬁcation showing the germinal center (GC) (40·) and (d) High magniﬁcation showing small
granulomas in the lymph node section (arrow) (40·) (H & E).
Figure 4 Photomicrograph of lymph node section of group B1 (second condition of the experiment). (a) Showing scattered epithelioid
granuloma (arrow): subcapsular or cortical and medullary (10·). (b) Showing high power of epithelioid cells (black arrows) forming
granuloma surrounded by collar of lymphocytes (LY), scattered apoptotic bodies (white arrows) (40·). (c) Showing lymphatic sinus
ectasia (arrow): epithelioid granuloma (EG) accompanied with lymphoid follicle atrophy (cortical atrophy) (10·); (d and e) Showing
epithelioid granuloma in a higher magniﬁcation power observing the epithelioid cells (arrows) (40·); (f) Showing lymphatic sinus ectasia
(white arrows); epithelioid granuloma (black arrows) accompanied with lymphoid follicles atrophy) (10·) (H & E).
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developed with light central zones or germinal centers
(Fig. 2a and b), the others are poorly developed and take
intensive stain without germinal centers (Fig. 2a).
The group immunized with rat collagen mixed with adju-
vant (group A1) is shown in Fig. 3. The LN in the rats in thesegroups (CIA) showed a decrease in the thickness of the cortex,
LN depletion and atrophy, with medullary hyperplasia
(Fig. 3a), lymphoid follicle with a pale staining area (germinal
center) (Fig. 3b and c) and small granulomas (Fig. 3d).
The histological examination of the LN section obtained
after the end of the second phase of the experiment of the
Figure 6 Photomicrograph of lymph node section of group A2 (1st condition of the experiment). (a) Showing distortion in architecture
of LN (10·). (b) Showing follicular hyperplasia (10·) (H & E).
Figure 5 Photomicrograph of lymph node section of group B2 (2nd condition of the experiment). (a) Showing scattered epithelioid
granuloma (EG), subcapsular or cortical or medullary accompanied with lymphoid follicle atrophy (10·). (b) Showing high power of
granuloma; macrophages with ill deﬁned borders and abundant cytoplasm surrounded by collar lymphocytes (LY) (40·) (H & E).
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antibodies accompanied with adjuvant (group B1) is shown
in Fig. 4. The section appeared ﬁlled with masses of histiocyte
cells (macrophages). The masses extend to medulla and distrib-
uted throughout the whole section, epithelioid granulomas
(Fig. 4a–f), high magniﬁcation power of these masses observed
(Fig. 6b, d and e) the epithelioid cells (cell with ill-deﬁned bor-
der, abundant cytoplasm and vesicular nucleus) forming gran-
uloma surrounded by collar of lymphocytes, scattered
apoptotic bodies, lymphatic sinus ectasia accompanied with
lymphoid follicles atrophy (cortical atrophy) appeared in the
tissue section (Fig. 4a,c and f).
The group treated with rat serum containing anti-rat
collagen alone (group B2) is shown in Fig. 5a and b, the sec-
tion appeared ﬁlled with epithelioid granulomas (foreign
body granuloma) which appear in higher microscopic power
as Epithelioid cells (cell with ill deﬁned border, abundant cyto-
plasm and vesicular nucleus) surrounded by collar of
lymphocytes.
The group immunized with bovine collagen mixed with
adjuvant (group A2) is shown in Fig. 6, The LN in the rats
in this groups showed distortion in architecture appeared
(Fig. 6a), follicular hyperplasia and reactive inﬂammatory
hyperplasia of the LN (Fig. 6b).
The group treated with serum of bovine collagen immu-
nized group accompanied with adjuvant (group B3) is shown
in Fig. 7. Follicular hyperplasia (Fig. 7a), tangible body mac-rophages and scattered apoptotic bodies inside the germinal
center (sign of hyperplasia) (Fig. 7b), and abnormal prolifera-
tion of plasma cells (Fig. 7c).
The group injected with serum containing anti-bovine colla-
gen antibodies without adjuvant (group B4) is shown in Fig. 8.
Loss of normal architecture (Fig. 8a), scattered granulomas
throughout the section (Fig. 8a and b), tangible body macro-
phages appeared in the section (Fig. 8c) and follicular hyper-
plasia (Fig. 8c and d).
The group injected with rat anti-BSA antibodies accompa-
nied with adjuvant (group B5) The group immunized with
BSA mixed with adjuvant (group A3) is shown in Fig. 9.
The LN in the rats in this group showed a distortion in archi-
tecture and an abnormal excess in the frame work of the LN
(Fig. 9a and b), with a follicular hyperplasia.
Shown in Fig. 10 are obliteration of subcapsular sinuses,
follicular hyperplasia and increase in the cortical area
(Fig. 10a), partial distortion of the architecture of the L.N
(Fig. 10b), nuclear clearing due to intra-nuclear inclusions
and apoptotic bodies that may have appeared (Fig. 10c).Discussion
Immunologic hypersensitivity to collagen, the major structural
component of the connective tissue, could explain both the sys-
temic nature and chronicity of the inﬂammation occurring in
Figure 7 Photomicrograph of lymph node section of graph B3 (2nd condition of the experiment): (a) Showing Tangible body
macrophages (arrows) and scattered apoptotic bodies inside the germinal center (40·). (c) Showing abnormal proliferation of plasma cells
(arrows) (40·). (d) Showing increase thickness of the subcapsular trabeculae in LN (40·). (e) Showing dilation of the sinusoids with blood
congestion (40·). (f) Showing aggregation of plasma cells (arrows) (40·) (H & E).
Figure 8 Photomicrograph of lymph node section of group B4 (2nd condition of the experiment): (a) Low microscopic power showing
distortion in architecture and scattered granulomas throughout the section (arrows) (4·). (b) Higher magniﬁcation power of granuloma
(srrows) (40·). (c) Showing Tangible body macrophages (arrows) (40·) and (d) showing hyperplasia of the germinal center (40·) (H & E).
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to collagen in sera from patients with rheumatoid arthritis sup-
port this premise (Steffen and Timpl, 1963; Steffen, 1970;
Michaeli and Fudenberg, 1974; Cracchiolo et. al., 1975; Andri-
opoulos et al., 1975, 1976). Also consistent with this hypothesis
is the distribution of collagen in structurally distinct types in
various tissues. For example, types I and III collagens are
found in the skin and parenchyma of several organs, whereas
type II exists in the cartilage (Serafﬁni-Fracassini and Smith,
1974).It is not uncommon for vaccine sites to hurt after vaccina-
tion. After all, the injection site of a vaccine is a site where an
aggressive immune inﬂammatory response is taking place and,
consequently, the region can be swollen, red and painful. Our
results indicated that the rats take ﬁve days to recover from the
side effects of vaccination. It was expected for joints to swell
and suffer inﬂammation due the anti-collagen inﬂammation
which indicate the success of proposed objectives of this study
(Fehrenbacher and M. R., 2012). The reason we mixed
collagen of rat or bovine and BSA with CFA is that collagen
Figure 9 Photomicrograph of lymph node section of group A3 (1st condition of the experiment). (a) Showing the excessive frame work
of the lymph node (10·). (b) Showing the increase in the normal frame work of lymph node (collagen like substance) in a higher power
(40·) (H & E).
Figure 10 Photomicrograph of lymph node section of group B5 (2nd condition of the experiment): (a) showing obliteration of
subcapsular sinuses, follicular hyperplasia and increase in the cortical area (4·), (b) showing partial distortion of the architecture of the
LN (10·) and (c) showing nuclear due to intra-nuclear inclusions (black arrows), apoptotic bodies appeared (white arrows) (40·) (H & E).
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less it is mixed with CFA (Trentham et al., 1977).
Adjuvant is a substance injected along with an antigen that
is intended to enhance the humoral and/or cell-mediated im-
mune response to the antigen. Adjuvant may have up to ﬁve
mechanisms of action: the ‘‘depot’’ effect, an antigen presenta-
tion effect, an antigen distribution or targeting effect, an im-
mune activation/modulation effect, and a CTL effect (Cox
and Coulter, 1997). Adjuvant generally permits the use of a
smaller antigen dose and may modulate the immune response
to the antigen. Adjuvant protects the antigen from both dilu-
tion and rapid degradation and elimination by the host. By
localizing and slowly releasing intact antigen, the adjuvant per-
mits a slow, prolonged exposure of the immune system cells to
a low level of antigen. This prolonged exposure results in con-
tinued stimulation of antibody producing cells, leading to pro-
duction of high levels of antibody by the host (Stills, 2005).
Lipopolysaccharides (LPS) used in this work acts as an
endotoxin, induces a strong response from normal animal im-
mune systems. It acts as the prototypical endotoxin because it
binds the CD14/TLR4/MD2 receptor complex, which pro-
motes the secretion of pro-inﬂammatory cytokines in many cell
types. Activation of different TLRs leads to different cellularand cytokine responses, which alters both the humoral and cel-
lular immune responses (Heldwein and Fenton, 2002; Nigou
et al., 2002; Means et al., 1999).
Lymph nodes function as ﬁlters of tissues and tissue ﬂuids
and are sites of origin and production of lymphocytes for nor-
mal physiological functions. As part of this normal function,
they react to both endogenous and exogenous substances with
a variety of speciﬁc morphological and functional responses.
Lesions can be both proliferative and non-proliferative, and
can be treatment-related or not. The histological evaluation
of lymph nodes is necessary in order to understand the immu-
notoxic effects of chemicals with the resulting data providing
an important component of animal risk assessment (Elmore,
2006a).
The group immunized with rat collagen mixed with adju-
vant (group A1) has shown a decrease in the thickness of
the cortex, lymph node depletion and atrophy, with medul-
lary hyperplasia, lymphoid follicle has a pale staining area
(germinal center) in the section, small granulomas appeared
in the section. Lymphocyte hyperplasia can involve both the
B-cell-rich follicles and the T-cell-rich paracortex and can be
indicative of a humeral or cell-mediated response,
respectively.
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sponse and is not considered to be a preneoplastic lesion in the
lymph node. Stimulated (reactive) follicles, also called second-
ary follicles, the case in group (A1), are usually larger than the
unstimulated primary follicles and will have a paler staining
germinal center with large lymphoblasts and increased num-
bers of apoptotic lymphocytes and tangible body macro-
phages. The mantle zone surrounding the germinal center is
composed of small to medium-sized darker staining B lympho-
cytes. Hyperplastic follicles are identiﬁed by an increase in the
number and size of follicles and conversion to secondary folli-
cles. Hyperplasia of the paracortex is characterized by an in-
crease in the cell density and, depending on the degree of
hyperplasia, an increase in the paracortical area (Elmore,
2006a). The decrease in the LN cortex is due to medullary
hyperplasia.
With the inﬂammation of Lymph nodes, it is accepted to
see a granuloma in LN. Lymphoid necrosis may either be fo-
cal, multifocal or diffuse within a lymph node and there can
be differences in the presence and severity of lymphoid necrosis
between lymph nodes in the same animal, depending on the
inciting factor and the effectiveness of the immune response
(Sainte-Marie et al., 1982).
The groups A2 and A3 have shown a remarkable distortion
in architecture appeared in the section, follicular hyperplasia
and reactive inﬂammatory hyperplasia of the LN which is
attributed to the foreignness of bovine collagen and BSA. This
led to more potent responses in the lymphoid tissue. The en-
larged germinal centers with B cell hyperplasia, are due to
the proliferation of blasts of B cell origin in the center (Van
den Broeck et al., 2006).
Autoantibody production is a characteristic of auto-immune
diseases such as rheumatoid arthritis. Correspondingly, in
mousemodels of autoimmune arthritis, it is well established that
Abs plays an essential role in disease development. In collagen-
induced arthritis (CIA), high titers of IgG against collagen type
II (CII) are essential for disease onset and transfer of the IgG to
naive mice induces arthritis (Wooley et al., 1981; Nandakumar
et al., 2003). In addition, mice lacking activating Fc gama recep-
tors for IgG are protected fromCIA, while absence of the inhib-
itory Fc gama RIIb results in augmented CIA (Diaz de Stahl
et al., 2002; Kleinau et al., 2000). Thus, Fc gama RIIb is a neg-
ative regulator of B cells dampening the signaling strength of the
B-cell receptor (BCR) and reducingAb secretion, particularly in
autoreactive B cells (Venkatesh et al., 2009).
The passive transfer of serum containing anti-rat collagen
antibodies to induce AIA, accompanied with adjuvant resulted
in masses of histiocyte cells that extend to medulla and distrib-
uted throughout the whole section, epithelioid granulomas,
epithelioid cells with ill-deﬁned border, abundant cytoplasm
and vesicular nucleus forming granuloma surrounded by collar
of lymphocytes, scattered apoptotic bodies, lymphatic sinus
ectasia accompanied with lymphoid follicle atrophy. Lympha-
tic sinus ectasia can involve both the medullary and subcapsu-
lar sinuses. Diffuse sinus ectasia is typically associated with
lymphoid atrophy. This lesion can be found in the mesenteric
and mediastinal lymph nodes of aging mice (Elmore, 2006a).
This lesion is characterized by the presence of dilated or cystic
sinuses lined by lymph endothelium and ﬁlled with pale eosin-
ophilic/amphophilic material that has a delicate lacy appear-
ance and a few lymphocytes, plasma cells and macrophages
mixed with the lymph.The passive transfer of rat serum containing anti-rat colla-
gen alone (group B2) has shown less severity where the section
appeared ﬁlled with epithelioid granulomas, thus reﬂects the
supportive role of adjuvant as indicated everywhere in the lit-
erature (Williams et al., 1997), but it does not eliminate the role
of passively transferred Anti collagen II antibodies in inducing
antibody induced arthritis (AIA).
Follicular hyperplasia, tangible body macrophages, scat-
tered apoptotic bodies inside the germinal center, and abnor-
mal proliferation of plasma cells were recorded for the group
treated with anti BSA serum (group B5). Plasma cells are usu-
ally increased in number in response to antigenic stimulation
that requires antibody production (Elmore, 2006a). Therefore
B cell hyperplasia can occur simultaneously with plasma cell
hyperplasia. Marked plasma cell hyperplasia, or plasmacyto-
sis, is a common ﬁnding in rodents. The medullary cords nor-
mally contain plasma cells and their precursors as the
dominant cell types and these cords are the primary sites of
plasma cell hyperplasia. In cases of marked plasma cell hyper-
plasia, the node can be greatly enlarged, composed almost en-
tirely of plasma cells, exhibit partial effacement of normal
nodal architecture, and can be difﬁcult to differentiate from
neoplasia. Findings that support hyperplasia are a lack of cor-
tical and capsular inﬁltration, typical plasma cells and metas-
tases (Haley et. al., 2005).
Macrophage hyperplasia usually results from proliferation
of resident sinusoidal macrophages but can also be seen as
aggregates ofmacrophageswithin any region of the lymphnode.
Macrophage aggregates can be peripherally located around the
paracortex or within the cortical, paracortical andmedullary re-
gions. Speciﬁc patterns (intrasinusoidal, cortical, paracortical,
medullary) of macrophage hyperplasia in the same node within
a dose group would be consistent with a treatment-related effect
(Bouwens et al., 1986). Thus the results in this work came out
with effective lymph node reactivity.
The different treatments used in this work either to induce
CIA or AIA, resulted in reactive lymph nodes with different de-
grees depending on the foreignness of stimulator and whether it
is accompanied with or without adjuvant which may be very
effective in inducing the symptoms. The inﬂammation of lymph
nodes clearly indicates a systemic inﬂammation where the se-
lected lymph nodes are not adjacent to the injection sites.Conclusion
In this work we established our own model for induction of
anti-collagen arthritis (CIA) in rats with focus on histological
changes of lymph node. The hallmark of this model is the reli-
able onset of robust inﬂammation. Antibody induced arthritis
(AIA) is faster than antigen induced arthritis, but there is a
possibility to be localized to the site of injection and its efﬁ-
ciency may be limited to the idiotypic determinants. While
we recommend the antigen induced model in this work, we
raise the warning sign of arthritic blood transfusion to healthy
ones.
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